Sertraline and Bemiparin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordBemiparin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Taking sertraline with bemiparin can raise your risk of bleeding. Sertraline is an antidepressant (an SSRI). One thing it does is make your platelets, the little cells that help your blood clot, a bit less able to do their job. Bemiparin is a blood thinner (a low molecular weight heparin) that already slows clotting. Put together, they can add up.
This doesn't mean you can't take both. Many people do safely. Just watch for easy bruising, nosebleeds, bleeding gums, or blood in your urine or stool, and tell your doctor or pharmacist. Your care team can keep an eye on you and adjust things if needed.
Effect: Additive increased bleeding risk (pharmacodynamic, not a CYP interaction). Neither agent is a prodrug here.
- Mechanism: SSRIs like sertraline deplete platelet serotonin, impairing platelet-mediated hemostasis; this adds to the anticoagulant effect of bemiparin (LMWH).
- Direction/onset: Enhanced bleeding tendency; delayed onset.
- Evidence: Probable, supported by case-control/cohort data for SSRI + anticoagulant combinations.
- Management: Monitor for bleeding (epistaxis, ecchymosis, hematoma, petechiae, GI/GU bleeding, signs of hemorrhage). Counsel patient on bleeding signs. Dose need not be fixed but should be individualized; increase clinical vigilance, especially with additional bleeding risk factors.
What happens
An increased risk of bleeding
Interaction Deep Dive
If sertraline is used together with an anticoagulant, watch the patient for indications of heightened bleeding and warn the patient about the elevated bleeding risk.1. Hemostasis depends in part on platelets releasing serotonin. Both case-control and cohort investigations have linked the joint use of SSRIs (sertraline among them) with anticoagulants to a greater bleeding risk 231. Taking sertraline alongside an anticoagulant may increase the likelihood of bleeding. Among the bleeding events that have been documented are epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that are life-threatening 1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
The good news: this combination can be managed by your care team with closer attention.
- Keep taking both exactly as prescribed unless your prescriber tells you otherwise.
- Watch for bleeding signs: unusual bruising, nosebleeds, bleeding gums, pink or red urine, black or bloody stools, or bleeding that won't stop.
- Your team may monitor you more closely and, if needed, adjust and individualize your treatment.
- Tell your pharmacist or doctor about any other medicines that thin blood, including aspirin, NSAIDs (like ibuprofen), or fish oil.
- Get prompt care for heavy or uncontrolled bleeding.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
4 reports — tap to read
a) A retrospective cohort study (n=234) reported an elevated risk of clinically relevant bleeding (defined as hospital admission caused by bleeding) among patients taking warfarin for atrial fibrillation while also receiving SSRI therapy or within 2 weeks after stopping SSRI therapy. Patients with a mean age of 72 +/- 7 years who received warfarin plus SSRI (n=117) were matched to randomly chosen patients treated with warfarin alone (n=117). The SSRIs used were FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, nine patients had 11 bleeding episodes over 213.9 treatment years, whereas in the warfarin-only group, 10 patients had 14 bleedings over 586.4 treatment years. The respective overall bleeding incidences were 51.4 and 23.9 per 1000 treatment years. Compared with warfarin alone, the hazard ratio for first bleedings during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009). The SSRIs involved in patients who bled during concurrent use were sertraline or citalopram. Adding an SSRI was not linked to a change in warfarin dose or INR (p=0.48 and p=0.31 respectively). The study's findings may be limited by prior bleeding events, uncertain patient adherence, and the exclusion of clopidogrel, dipyridamol, corticosteroids, and anticoagulants other than warfarin from the model 2.
b) A population-based, case-controlled study of new coumarin users (acenocoumarol and phenprocoumon) taking concomitant selective serotonin reuptake inhibitors (SSRIs) found an increased risk of hospitalization for non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records in the Netherlands, investigators identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also on a coumarin. The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients receiving SSRIs had a higher risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly 3.
c) In a non-blinded, randomized, placebo-controlled trial with 12 healthy volunteers, researchers evaluated the effect of sertraline on the plasma protein binding of warfarin. On days and 32 of the study, all participants received warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to either the sertraline or placebo group; the sertraline dose was progressively raised from 50 mg/day to 200 mg/day. Prothrombin time was measured before each warfarin dose and at intervals afterward. The investigators concluded that sertraline did not enhance warfarin's anticoagulant effects to a clinically significant extent, even though sertraline was administered at a higher-than-usual dose 4.
d) Case reports and epidemiological studies (case-control and cohort studies) have shown an association between the use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on data from published observational studies, exposure to SSRIs, especially in the month before delivery, has been linked to a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events associated with SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Sertraline and Bemiparin together?
Sertraline and bemiparin together can add up to a higher bleeding risk, so keep taking both as prescribed but watch for bruising or bleeding and report it to your care team. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Bemiparin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Sertraline and Bemiparin interaction managed?
The good news: this combination can be managed by your care team with closer attention. Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Watch for bleeding signs: unusual bruising, nosebleeds, bleeding gums, pink or red urine, black or bloody stools, or bleeding that won't stop. Your team may monitor you more closely and, if needed, adjust and individualize your t… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Bemiparin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Keep reading about Sertraline
Keep reading about Bemiparin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist